Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKesson
Dow
Medtronic
Baxter
AstraZeneca
Mallinckrodt

Last Updated: December 13, 2019

DrugPatentWatch Database Preview

Corepharma Company Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the competitive landscape for COREPHARMA, and what generic and branded alternatives to COREPHARMA drugs are available?

COREPHARMA has one approved drug.

There is one tentative approval on COREPHARMA drugs.

Summary for Corepharma
US Patents:0
Tradenames:1
Ingredients:1
NDAs:1
Patent Litigation for Corepharma: See patent lawsuits for Corepharma

Drugs and US Patents for Corepharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Corepharma DECLOMYCIN demeclocycline hydrochloride TABLET;ORAL 050261-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Corepharma DECLOMYCIN demeclocycline hydrochloride TABLET;ORAL 050261-003 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Corepharma DECLOMYCIN demeclocycline hydrochloride TABLET;ORAL 050261-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Merck
Colorcon
Express Scripts
Moodys
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.